Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaclyn F Hechtman

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
Cancer|April 17, 2014
BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancerRona Yaeger, Andrea Cercek, Joanne F Chou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 17, 2016
Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology-molecular associations: clinical and biological implicationsJinru Shia, Nikolaus Schultz, Deborah Kuk, et al.
Cancer Research|September 28, 2017
Mechanisms of Acquired Resistance to BRAF V600E Inhibition in Colon Cancers Converge on RAF Dimerization and Are Sensitive to Its InhibitionRona Yaeger, Zhan Yao, David M Hyman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 9, 2019
Colorectal carcinoma with double somatic mismatch repair gene inactivation: clinical and pathological characteristics and response to immune checkpoint blockadeTao Wang, Lik Hang Lee, Monika Vyas, et al.
The Oncologist|May 11, 2025
Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumorsIan Nykaza, Yonina R Murciano-Goroff, Antoine Desilets, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 10, 2024
Evidence for Unified Assessment Criteria of HER2 Immunohistochemistry in Colorectal CarcinomaMark G Evans, Harris B Krause, Joanne Xiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2019
TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver MutationsEzra Y Rosen, Debra A Goldman, Jaclyn F Hechtman, et al.
Cancer Discovery|June 23, 2019
V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon CancerYijun Gao, Ann Maria, Na Na, et al.
Human Pathology|December 31, 2016
Diagnosing colorectal medullary carcinoma: interobserver variability and clinicopathological implicationsLik Hang Lee, Rhonda K Yantiss, Eran Sadot, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 23, 2016
Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinomaLik Hang Lee, Marcela S Cavalcanti, Neil H Segal, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Cancer|April 17, 2014
BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancerRona Yaeger, Andrea Cercek, Joanne F Chou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 17, 2016
Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology-molecular associations: clinical and biological implicationsJinru Shia, Nikolaus Schultz, Deborah Kuk, et al.
Cancer Research|September 28, 2017
Mechanisms of Acquired Resistance to BRAF V600E Inhibition in Colon Cancers Converge on RAF Dimerization and Are Sensitive to Its InhibitionRona Yaeger, Zhan Yao, David M Hyman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 9, 2019
Colorectal carcinoma with double somatic mismatch repair gene inactivation: clinical and pathological characteristics and response to immune checkpoint blockadeTao Wang, Lik Hang Lee, Monika Vyas, et al.
The Oncologist|May 11, 2025
Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumorsIan Nykaza, Yonina R Murciano-Goroff, Antoine Desilets, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 10, 2024
Evidence for Unified Assessment Criteria of HER2 Immunohistochemistry in Colorectal CarcinomaMark G Evans, Harris B Krause, Joanne Xiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2019
TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver MutationsEzra Y Rosen, Debra A Goldman, Jaclyn F Hechtman, et al.
Cancer Discovery|June 23, 2019
V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon CancerYijun Gao, Ann Maria, Na Na, et al.
Human Pathology|December 31, 2016
Diagnosing colorectal medullary carcinoma: interobserver variability and clinicopathological implicationsLik Hang Lee, Rhonda K Yantiss, Eran Sadot, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 23, 2016
Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinomaLik Hang Lee, Marcela S Cavalcanti, Neil H Segal, et al.
Pageof 12